Secondary hypertension
268 results
1 - 100
Secondary hypertension
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
Useful history, physical, and laboratory findings for predicting secondary hypertension in children and adolescents
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
Fewer than 4% of children with newly diagnosed hypertension in primary care or school settings have secondary causes
Hypertension: investigations, treatment initiation and non-pharmacological treatment
Hypertension in children
Phosphodiesterase 5 inhibitors for pulmonary hypertension
Intracerebral haemorrhage
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials: Cochrane systematic review
Cushing's syndrome
Intracranial aneurysm and subarachnoid haemorrhage (SAH)
Drug treatment for hypertension
Phosphodiesterase 5 inhibitors for pulmonary hypertension: Cochrane systematic review
Prostacyclin for pulmonary hypertension in adults
Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
Roselle for hypertension in adults
Spironolactone for hypertension
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus: Cochrane systematic review
Angiotensin receptor blockers or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation
Antiplatelet agents and anticoagulants for hypertension
New US guidelines suggest risk-based approach to stage 1 hypertension
Hypertension treatment effective even after age 80
Hydralazine for essential hypertension
Weak evidence that optimal neonatal outcomes are associated with delivery at 39 weeks for pregnant individuals with mild chronic hypertension
Venous insufficiency of the lower limbs
Treatment of mild chronic hypertension during pregnancy is beneficial
Bariatric surgery in obese patients with hypertension can produce normotension in some of them (GATEWAY)
First‐line drugs for hypertension
Beta‐blockers for preventing stroke recurrence
Treatment of hypertension in peripheral arterial disease
Methyldopa for primary hypertension: Cochrane systematic review
Phosphodiesterase 5 inhibitors for pulmonary hypertension
Renin inhibitors versus angiotensin receptor blockers for primary hypertension
Cesarean rates and neonatal outcomes similar with induction vs expectant management with unripe cervix
Raynaud's phenomenon (RP) or white finger disease
Hypokalaemia
Headache
Inhaled iloprost for pulmonary hypertension
Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction: Cochrane systematic review
Guided imagery for treating hypertension in pregnancy
Riociguat for pulmonary hypertension
ASA for hypertension
Eplerenone for hypertension
IgA nephropathy
Pharmacotherapy for mild hypertension
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
Cerebral infarction (ischaemic stroke)
Interventions for altering blood pressure in people with acute subarachnoid haemorrhage
Long‐term effects of weight‐reducing diets in people with hypertension
Guanylate cyclase stimulators for pulmonary hypertension
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Glomerulonephrites
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Pharmacotherapy for mild hypertension
Different types of dietary advice for women with gestational diabetes mellitus
Pharmacotherapy for hypertension in adults 60 years or older
Higher BP target does not reduce mortality in septic patients (SEPSISPAM)
Proteinuria
Blood pressure targets in adults with hypertension
Prostacyclin for pulmonary hypertension
